Trial Profile
Response between active and passive follow ups in patients with chronic hepatitis C during treatment with Sofosbuvir/Ledipasvir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 09 Jul 2017 New trial record